ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 114 filers reported holding ANAPTYSBIO INC in Q1 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $780,218 | -11.7% | 43,442 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $883,610 | -6.5% | 43,442 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $945,298 | -29.8% | 43,442 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,346,268 | +9.5% | 43,442 | -9.9% | 0.00% | 0.0% |
| Q3 2022 | $1,230,000 | +33.6% | 48,242 | +6.4% | 0.00% | +50.0% |
| Q2 2022 | $921,000 | -17.9% | 45,342 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,122,000 | -28.0% | 45,342 | +1.1% | 0.00% | -33.3% |
| Q4 2021 | $1,558,000 | +32.3% | 44,832 | +3.2% | 0.00% | +50.0% |
| Q3 2021 | $1,178,000 | +247.5% | 43,442 | +88.8% | 0.00% | +100.0% |
| Q3 2020 | $339,000 | – | 23,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |